Late reperfusion after acute myocardial infarction;Spate Reperfusion bei akutem Myokardinfarkt

Deutsche Medizinische Wochenschrift

Volumn 122, Issue 13, 1997, Pages 415-421

  Michel, C J ^a   Heintzen, M P ^a   Strauer, B E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; FIBRINOLYSIS; HUMAN; REPERFUSION; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; CORONARY BLOOD VESSEL; HEART INFARCTION; HEART MUSCLE REPERFUSION; METHODOLOGY; PATHOPHYSIOLOGY; TIME; VASCULAR PATENCY;

CORONARY VESSELS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; TIME FACTORS; VASCULAR PATENCY;

EID: 0031587723     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1047631     Document Type: Review

References (64)

1. Alhaddad, I. A., R. A. Kloner, I. Hakim, J. L. Garno, E. J. Brown: Benefits of late coronary artery reperfusion on infarct expansion progressively diminish over time. Relation to viable islets of myocyte within the scar. Amer. Heart J. 131 (1996), 451-457.
2. Althouse, R., C. Maynard, M. Olsufka, J. Kennedy: Incidence of contraindications to thrombolysis in patients with myocardial infarction. Circulation 78, Suppl. II (1988), 211.
3. Anderson, J. L., L. A. Karanougis, L. C. Becker, S. G. Sorensen, R. L. Menlove TEAM 3 Investigators: TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Circulation 87 (1993), 1829-1839.
4. Becker, R. C.: Late thrombolytic therapy. Mechanism of benefit and potential risk among patients treated beyond 6 hours. Coronar. Art. Dis. 4 (1993), 293-304.
5. Bulkley, B. H., G. M. Hutchins: Myocardial consequences of coronary artery bypass graft surgery. The paradox of necrosis in areas of revascularisation. Circulation 56 (1977), 906-909.
6. Cragg, D. R., H. Z. Friedman, J. D. Bonema, I. A. Jaiyesimi, R. G. Ramos, G. C. Timmis, W. W. O'Neill, T. L. Schreiber: Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy. Ann. intern. Med. 115 (1991), 173-177.
7. Cribier, A., L. Korsatz, R. Koning, P. Rath, H. Gamra, G. Stix, S. Merchant, C. Chan, B. Letac: Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty. A prospective study. J. Amer. Coll. Cardiol. 20 (1992), 578-586.
8. Dalen, J. E., J. M. Gore, E. Braunwald, J. Borer, R. J. Goldberg, E. R. Passamani, S. Forman, G. Knatterud, TIMI Investigators: Six- and twelve-month follow-up of the phase I thrombolysis in Myocardial Infarction Trial. Amer. J. Cardiol. 62 (1988), 179-185.
9. DeWood, M. A., J. Spores, R. Notske, L. T. Mouser, R. Burroughs, M. S. Golden, H. T. Lang: Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. New Engl. J. Med. 303 (1980), 897-902.
10. Doorey, A. J., E. L. Michelson, F. J. Weber, L. S. Dreifus: Thrombolytic therapy of acute myocardial infarction. Emerging challenges of implementation. J. Amer. Coll. Cardiol. 10 (1987), 1357-1360.
11. EMERAS (Estudio Multicéntrico Estreptoquinasa Républicas de América del Sur) Collaborative Group: Randomized trial of late thrombolysis in patients with suspected acute myocardial infarction. Lancet 342 (1993), 767-772.
12. Fibrinolytic Therapy Trialists (FTT) Collaborative Group: Indications for fibrinolytic therapy in suspected acute myocardial infarction. Collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 343 (1994), 311-322.
13. Grines, C L., K. F. Browne, J. Marco, D. Rothbaum, G. W. Stone, J. O'Keefe, O. Overlie, B. Donohue, N. Chelliah, G. C. Timmis, R. E. Vlietstra, M. Strzelecki, S. Puchrowicz-Ochoki, W. W. O'Neill, Primary Angioplasty in Myocardial Infarction Study Group: A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. New Engl. J. Med. 328 (1993), 673-679.
14. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardio (GISSI): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986/1, 397-402.
15. Habib, G. B., J. Heibig, S. A. Forman, B. G. Brown, R. Roberts, M. L. Terrin, R. L. Bolli: Influence of coronary collateral vessels on myocardial infarct size in humans. Circulation 83 (1991), 739-746.
16. Hale, S. L., R. A. Kloner: Left ventricular topographic alterations in the completely healed rat infarct caused by early and late coronary artery perfusion. Amer. Heart J. 116 (1988), 1508-1513.
17. Hartzler, G. O., B. D. Rutherford, D. R. McConahay: Percutaneous transluminal coronary angioplasty. Application for acute myocardial infarction. Amer. J. Cardiol. 53 (1984), 117-121.
18. Hashimoto, T., H. Kambara, T. Fudo, M. Hayashi, S. Tamaki, S. Tokunaga, N. Tamaki, Y. Yonekura, J. Konishi, C. Kawai: Non-Q-wave vs Q-wave myocardial infarction. Regional myocardial metabolism and blood flow assessed by positron emission tomography. J. Amer. Coll. Cardiol. 12 (1988), 88-93.
19. Heintzen, M. P., W. Motz, M. Leschke, H. P. Schultheiß, D. Horstkotte, E. G. Vester, L. Wahbe, T. Ries, H. Pütz, P. Sommer, K. Pels, H. D. Schulte, B. E. Strauer: PTCA im Stadium des akuten Myoardinfarktes. Hospitalverlauf von 785 konsekutiven Patienten. Z. Kardiol. 83 (1994), 404-413.
20. Jorayama, A., T. Adachi, S. Asada, M. Mishima, S. Nanto, H. Kusuoka, K. Yamamoto, Y. Matsumura, M. Hori, M. Inoue, K. Kodama: Late reperfusion for acute myocardial infarction limits the dilatation of left ventricle without the reduction of infarct size. Circulation 88 (1993), 2565-2574.
21. Hochmann, J. S., H. Choo: Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 75 (1987), 299-306.
22. Holmes, D. R., K. B. Davies, M. B. Mock, L. D. Fisher, B. J. Gersh, T. Killip, Coronary Artery Surgery Study Group: The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease. A report from the CASS-Study. Circulation 73 (1986), 1254-1263.
23. Holmes, J. W., H. Yamashita, L. K. Waldman, J. W. Covell: Scar remodeling and transmural deformation after infarction in the pig. Circulation 90 (1994), 411-420.
24. Horvitz, L. L., J. F. Pietrolungo, R. S. Suri, I. Castle, R. Trohman, J. D. Maloney : An open infarct-related artery is associated with a lower risk of lethal ventricular arrhythmias in patients with a left ventricular aneurysm. Circulation 86, Suppl. I (1992), 315.
25. Huikuri, H. V., M. J. Koistinen, K. E. Airaksinen, M. J. Ikaheimo: Significance of perfusion of the infarct patent related coronary artery for suspectibility to ventricular tachyarrhythmias in patients with previous myocardial infarction. Heart 75 (1996), 17-22.
26. ISAM Study Group: A prospective trial of intravenous streptokinase in acute myocardial infarction (I. S. A. M.). New Engl. J. Med. 314 (1986), 1465-1471.
27. ISIS-2: Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected acute myocardial infarction. Lancet 1988/III, 349-360.
28. Jaggers, J. D., R. G. Murray, M. K. Davies, W. A. Littler, E. J. Flint: Eligibility for thrombolytic therapy in acute myocardial infarction. Lancet 1987/I, 34-35.
29. Jennings, R. B., H. M. Sommers, P. B. Herdson, J. P. Kaltenbach: Ischemic injury of myocardium. Ann. N. Y. Acad. Sci. 156 (1969), 61.
30. Jennings, R. B., C. Steenbergen jr., D. B. Hackel: The heart. In Rubin, E., J. L. Farber (Ed.): Pathology (Lippincott: Philadelphia 1994), 502-555.
31. Judgutt, B. I., R. W. M. Amy: Healing after myocardial infarction in the dog. Changes in infarct hydroxyproline and topography. J. Amer. Coll. Cardiol. 7 (1986), 91-102.
32. Karam, C., J. Goldmard, P. G. Steg: Decreased prevalence of late potentials with mechanical versus thrombolysis-induced reperfusion in acute myocardial infarction. J. Amer. Coll. Cardiol. 27 (1996), 1343-1348.
33. Kennedy, J. A., J. L. Ritchie, K. B. Davis, J. K. Fritz: Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. New Engl. J. Med. 309 (1983), 1477-1482.
34. Kennedy, J. W., J. L. Ritchie, K. B. Davis, M. L. Stadius, C. Maynard, J. K. Fritz: The Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report. New Engl. J. Med. 312 (1985), 1073-1078.
35. Killip, T., J. T. Kimball: Treatment of myocardial infarction in a coronary care unit. Amer. J. Cardiol. 20 (1967), 457-464.
36. Kim, C. B., E. Braunwald: Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis. Circulation 88 (1993), 2426-2436.
37. Lamas, G. A., G. C. Flaker, G. Mitchell, S. C. Smith, B. J. Gersh, C. C. Wun, J. L. Moyé, L. Rouleau, J. D. Rutherford, M. A. Pfeffer, E. Braunwald: Effect of infarct artery patency on prognosis after acute myocadial infarction. Circulation 92 (1995), 1101-1109.
38. Lange, R. A., R. G. Cigarroa, P. J. Wells, M. S. Kremers, L. D. Hillis: Influence of anterograde flow in the infarct artery on the incidence of late potentials after acute myocardial infarction. Amer. J. Cardiol. 65 (1990), 554-558.
39. LATE Study Group: Late assessment of thrombolytic efficacy (LATE) study with alteplase after onset of acute myocardial infarction. Lancet 342 (1993), 759-766.
40. Lenderik, T., M. L. Simoons, G. E. Van Es, F. van de Werf, M.Verstraete, A. E. R. Arnold, European Cooperative Study Group: Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 at discharge. Circulation 92 (1995), 1110-1116.
41. Marokko, P. R., P. Libby, W. R. Ginks, C. M. Bloor, W. E. Shell, B. E. Sobel, J. Ross jr.: Coronary artery reperfusion I. Early effects on local myocardial function and the extent of myocardial necrosis. J. clin. Invest. 5 (1972), 2710-2716.
42. McCormick, R. J., T. I. Musch, B. C. Bergmann, D. P. Thomas: Regional differences in LV collagen accumulation and mature cross-linking after myocardial infarction in rats. Amer. J. Physiol. 266 (1994), 354-359.
43. Meyer, J., W. Merx, H. Schmitz, R. Erbel, T. Kiesslich, R. Dorr, H. Lambertz, C. Bethge, W. Krebs, P. Bardos, C. Minale, B. J. Messmer, S. Effert: Percutaneous transluminal angioplasty immediately after intracoronary streptolysis after transmural myocardial infarction. Circulation 66 (1982), 905-913.
44. Michel, C. J., M. P. Heintzen, M. Leschke, E. G. Vester, B. E. Strauer: Ergebnisse der Spät-Reperfusion (> 6 h) mittels PTCA bei Patienten mit akutem Myokardinfarkt. Z. Kardiol. 85, Suppl. 2 (1996), 139.
45. Mortara, A., G. Specchia, M. T. La Rovere, J.T. Bigger, F. I. Marcus, J. A. Camm, S. H. Hohnloser, R. Nohara, P. J. Schwartz, ATRAMI Investigators: Patency of infarct related artery. Effect of restoration of anterograde flow on vagal reflexes. Circulation 93 (1996), 1114-1122.
46. Murray, C. E., R. B. Jennings, K. A. Reimer: Preconditioning with ischemia. A delay of lethal cell injury in ischemic myocardium. Circulation 5 (1986), 1124-1136.
47. Murray, N., J. Lyons, C. Layton, R. Balcon: What proportion of patients with acute myocardial infarction are suitable for thrombolysis? Brit. Heart J. 57 (1987), 144-147.
48. Reimer, K. A., R. B. Jennings: The changing anatomic reference base of evolving myocardial infarction. Underestimation of myocardial collateral blood flow and overestimation of experimental anatomic infarct size due to tissue edema, hemorrhage and acute inflammation. Circulation 60 (1979), 866.
49. Reimer, K.A., R. B. Jennings: Myocardial ischemia, hypoxia and infarction. In Fozzard, H. A., E. Haber, R. B. Jennings, A. M. Katz, H. E. Morgan (Ed.): The Heart and Cardiovascular System, Vol. 2 (Raven: New York 1991), 1875-1974.
50. Rentrop, P., H. Smith, L. Painter: Changes in left ventricular ejection fraction after intracoronary thrombolytic therapy. Circulation 68, Suppl. I (1983), 55-60.
51. Ritchie, J. L., K. B. Davis, D. L. Williams, J. Caldwell, J. W. Kennedy: Global and regional left ventricular function and tomographic radionuclide perfusion. The Western Washington Intracoronary Streptokinase in Myocardial infarction Trial. Circulation 70 (1984), 867-875.
52. Roberts, C. S., F. J. Schoen, R. A. Kloner: Effect of coronary reperfusion on myocardial infarct healing and hemorrhage. Amer. J. Cardiol. 52 (1983), 610-614.
53. Rogers, W. J., J. P. Hood, J. A. Mantle, W. A. Baxley, J. K. Kirklin, G. L. Zorn, H. P. Nath: Return of left ventricular function after reperfusion in patients with myocardial infarction. Importance of subtotal stenoses or intact collaterals. Circulation 69 (1984), 338-349.
54. Salisbury, P. F., C. E. Cross, P. A. Rieben: Influence of coronary artery pressure upon myocardial elasticity. Circulat. Res. 8 (1960), 794-800.
55. Steinberg, J. S., J. S. Hochmann, C. P. Morgan, P. Dorian, P. Theroux, E. J. Topol, P. W. Armstrong, LATE Ancillary Investors: The effects of thrombolytic therapy administered 6-24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. J. Amer. Coll. Cardiol. 21 (1993), 225 (Abstract).
56. Strauer, B. E., U. E. Heidland, M. P. Heintzen, B. Schwartzkopff: Pharmakologische Präkonditionierung während perkutaner transluminaler Coronarangioplastie durch Dipyridamol intrakoronar. Hämodynamische, kontraktile und ventrikeldynamische Konsequenzen. Z. Kardiol. 84 (1995), 898-910.
57. The GUSTO Angiographic Investigators: The effects of tissue plasminogen activator, streptokinase or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. New Engl. J. Med. (1993), 1615-1622.
58. The TIMI Study Group: Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction (TIMI) phase II trial. New Engl. J. Med. 320 (1989), 618-627.
59. TIMI Research Group: Thrombolysis in myocardial infarction (TIMI) trial, phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 76 (1987), 142-154.
60. Topol, E. J., R. M. Califf, M. Vandormael, C. L. Grines, B. S. George, M. L. Sanz, T. Wall, M. O'Brien, M. Schwaiger, F. V. Aguirre, S. Young, J. J. Popma, K. N. Sigmon, K. L. Lee, S. G. Ellis, Thrombolysis and Angioplasty in Myocardial Infarction -6 Study Group: A randomized trial of late reperfusion therapy for acute myocardial infarction. Circulation 85 (1992), 2090-2099.
61. Weaver, W. D., J. Martin, P. Litwin, M. Eisenberg, M. Ho, P. Kudenchuk, MITI: Project report on phase I. Feasability, characteristics of patients. J. Amer. Coll. Cardiol. 13, Suppl. A (1989), 152 (Abstract).
62. Wilcox, R. G., G. von der Lippe, C. G. Olsson, G. Jensen, A. M. Skene, J. R. Hampton, ASSET Study Group: Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Lancet 1988/II, 525-530.
63. Yusuf, S., R. Collins, R. Peto, C. Furberg, M. J. Stampfer, S. Z. Goldhaber, C. H. Hennekens: Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction. Overview of results on mortality, reinfarction and side effects from 33 randomized controlled trials. Europ. Heart J. 6 (1985), 556-585.
64. Zaret, B. L., F. J. Walkers, M. Terrin, R. Ross, G. Knatterud, E. Braunwald, TIMI Investigators: Does left ventricular ejection fraction following thrombolytic therapy have the same prognostic impact described in the prethrombolytic era? Results of the TIMI II trial. J. Amer. Coll. Cardiol. 17 (1991), 214 (Abstract).